4//SEC Filing
Machatha Stephen 4
Accession 0000899243-23-006748
CIK 0001341235other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:27 PM ET
Size
5.6 KB
Accession
0000899243-23-006748
Insider Transaction Report
Form 4
Machatha Stephen
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-28+220,258→ 220,258 totalExercise: $6.76Exp: 2033-02-27→ Common Stock (220,258 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2023.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001836354
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:27 PM ET
- Size
- 5.6 KB